Friday 6 November 2026
Export GEHC’s income statement to Excel — free account
GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.
- Revenue
- +7.19%
- EPS
- +40.6%
- Free cash flow
- +64.2%
- Total debt
- −1.90%
Quarter to September 2026, against a year earlier
82.39
1.36
−1.62%
Follow GEHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
17.99 | 17.03 | 14.68 | 13.74 |
P/S ratio |
1.81 | 1.55 | 1.36 | 1.37 | |
P/FCF ratio |
24.85 | 21.37 | 18.36 | 15.64 | |
P/Operating CF |
35.62 | 111.92 | 172.60 | 32.58 | |
P/B ratio |
3.60 | 3.04 | 2.64 | 2.54 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.16 | 1.99 | 1.81 | 1.77 | |
EV/EBITDA |
13.34 | 12.86 | 11.50 | 10.91 | |
EV/Operating CF |
22.42 | 20.58 | 18.29 | 15.86 | |
EV/FCF |
29.61 | 27.47 | 24.33 | 20.27 | |
Quick Ratio |
0.93 | 0.71 | 0.72 | 0.77 | |
Current Ratio |
1.37 | 1.22 | 1.26 | 1.30 | |
Net Debt/EBITDA |
7.34 | 13.87 | 10.49 | 9.04 | |
Debt/Assets |
31.62% | 31.12% | 30.96% | 30.23% | |
Debt/Equity |
1.12 | 1.08 | 1.05 | 1.00 | |
Asset Turnover |
0.59 | 0.59 | 0.58 | 0.58 | |
Operating CF/Net income |
1.79 | 0.75 | 0.30 | 1.47 | |
Capex/Depreciation |
(0.92) | (1.16) | (0.62) | (0.70) | |
Research and Development Expense of Revenue |
5.65% | 6.72% | 6.10% | 5.80% | |
Selling, General and Administrative Expense of Revenue |
19.50% | 21.77% | 21.11% | 19.95% | |
Intangible Assets out of Total Assets |
0.40 | 0.46 | 0.46 | 0.44 | |
Share Based Compensation of Revenue |
0.63% | 0.68% | 0.85% | 0.65% | |
Graham Net Nets |
(0.37) | (0.49) | (0.54) | (0.52) | |
Graham Number |
48.35 | 46.94 | 48.78 | 52.49 | |
Earnings Yield |
5.56% | 5.87% | 6.81% | 7.28% | |
Free Cash Flow Yield |
4.02% | 4.68% | 5.45% | 6.39% | |
Revenue per Share |
12.50 | 11.25 | 11.69 | 12.20 | |
Operating CF per Share |
2.30 | 0.64 | 0.37 | 2.01 | |
Capex per Share |
(0.29) | (0.39) | (0.22) | (0.25) | |
Free Cash Flow per Share |
2.01 | 0.25 | 0.15 | 1.75 | |
Cash per Share |
9.89 | 5.01 | 4.65 | 6.31 | |
Shareholders Equity per Share |
22.79 | 23.42 | 24.26 | 25.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.79 | 23.42 | 24.26 | 25.73 | |
Free Cash Flow |
916.00 | 112.00 | 68.00 | 793.00 | |
Working Capital |
3,396.00 | 1,897.00 | 2,195.00 | 2,680.00 | |
Capital Expenditures |
(134.00) | (178.00) | (100.00) | (114.00) | |
Net Current Asset Value |
(14,015.00) | (16,019.00) | (15,760.00) | (15,246.00) | |
EV/EBIT |
16.13 | 15.75 | 14.05 | 13.26 | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | |
Price to Operating Income |
13.54 | 12.25 | 10.60 | 10.23 | |
| Other line items | |||||
Average Receivables |
3,760.50 | 3,679.00 | 3,721.50 | 3,829.50 | |
Average Payables |
3,142.50 | 3,281.00 | 3,103.00 | 3,153.50 | |
Average Inventory |
2,086.50 | 2,255.50 | 2,383.00 | 2,466.00 | |
Average Assets |
34,997.50 | 35,355.50 | 36,373.00 | 37,249.00 | |
Average Common Equity |
9,427.50 | 9,944.50 | 10,361.50 | 10,823.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026